NewsBenzingaElevance Health Q3 Adj. EPS $6.99 Beats $4.68 Estimate, Sales $50.440B Beat $49.213B Estimate Elevance Health Q3 Adj. EPS $6.99 Beats $4.68 Estimate, Sales $50.440B Beat $49.213B Estimate Benzinga 2026.10.21 10:01 (GMT+0) Open on Benzinga Other news Winnebago Industries Q4 2026 Earnings Call Transcript RBC Capital Maintains Sector Perform on ONEOK, Raises Price Target to $96 Danaher Beats Profit Estimates, Raises Outlook as Customer Demand Improves JP Morgan Maintains Overweight on Netflix, Lowers Price Target to $81 RBC Capital Maintains Outperform on KeyCorp, Lowers Price Target to $24 JP Morgan Maintains Overweight on Hyatt Hotels, Lowers Price Target to $207
